Lebwohl, MG, J Sugarman, DM Pariser, J Bagel, T Lin, and R Israel. “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine 4, no. 1 (January 28, 2020): S12. Accessed December 10, 2022. https://www.jofskin.org/index.php/skin/article/view/826.